186 related articles for article (PubMed ID: 36613820)
1. Targeting MYC Regulation with Polypurine Reverse Hoogsteen Oligonucleotides.
Valiuska S; Psaras AM; Noé V; Brooks TA; Ciudad CJ
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613820
[TBL] [Abstract][Full Text] [Related]
2. Targeting KRAS Regulation with PolyPurine Reverse Hoogsteen Oligonucleotides.
Psaras AM; Valiuska S; Noé V; Ciudad CJ; Brooks TA
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216221
[TBL] [Abstract][Full Text] [Related]
3. Effect of Polypurine Reverse Hoogsteen Hairpins on Relevant Cancer Target Genes in Different Human Cell Lines.
Villalobos X; Rodríguez L; Solé A; Lliberós C; Mencia N; Ciudad CJ; Noé V
Nucleic Acid Ther; 2015 Aug; 25(4):198-208. PubMed ID: 26042602
[TBL] [Abstract][Full Text] [Related]
4. Polypurine reverse-Hoogsteen (PPRH) oligonucleotides can form triplexes with their target sequences even under conditions where they fold into G-quadruplexes.
Solé A; Delagoutte E; Ciudad CJ; Noé V; Alberti P
Sci Rep; 2017 Jan; 7():39898. PubMed ID: 28067256
[TBL] [Abstract][Full Text] [Related]
5. Polypurine reverse Hoogsteen hairpins as a gene therapy tool against survivin in human prostate cancer PC3 cells in vitro and in vivo.
Rodríguez L; Villalobos X; Dakhel S; Padilla L; Hervas R; Hernández JL; Ciudad CJ; Noé V
Biochem Pharmacol; 2013 Dec; 86(11):1541-54. PubMed ID: 24070653
[TBL] [Abstract][Full Text] [Related]
6. Detection of a G-Quadruplex as a Regulatory Element in
Aubets E; J Félix A; Garavís M; Reyes L; Aviñó A; Eritja R; Ciudad CJ; Noé V
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708710
[TBL] [Abstract][Full Text] [Related]
7. Targeted Downregulation of MYC through G-quadruplex Stabilization by DNAi.
Psaras AM; Chang KT; Hao T; Brooks TA
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577013
[TBL] [Abstract][Full Text] [Related]
8. Polypurine Reverse Hoogsteen Hairpins as a Gene Silencing Tool for Cancer.
Ciudad CJ; Rodríguez L; Villalobos X; Félix AJ; Noé V
Curr Med Chem; 2017; 24(26):2809-2826. PubMed ID: 28260512
[TBL] [Abstract][Full Text] [Related]
9. Human MYC G-quadruplex: From discovery to a cancer therapeutic target.
Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between G-Quadruplexes and Dnmt3a-Mediated Methylation of the
Sergeev AV; Loiko AG; Genatullina AI; Petrov AS; Kubareva EA; Dolinnaya NG; Gromova ES
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203216
[TBL] [Abstract][Full Text] [Related]
11. Piperine analogs arrest c-myc gene leading to downregulation of transcription for targeting cancer.
Pandya N; Kumar A
Sci Rep; 2021 Nov; 11(1):22909. PubMed ID: 34824301
[TBL] [Abstract][Full Text] [Related]
12. G-quadruplex DNA structure is a positive regulator of
Esain-Garcia I; Kirchner A; Melidis L; Tavares RCA; Dhir S; Simeone A; Yu Z; Madden SK; Hermann R; Tannahill D; Balasubramanian S
Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2320240121. PubMed ID: 38315865
[TBL] [Abstract][Full Text] [Related]
13. Nucleic acids therapeutics using PolyPurine Reverse Hoogsteen hairpins.
Noé V; Aubets E; Félix AJ; Ciudad CJ
Biochem Pharmacol; 2021 Jul; 189():114371. PubMed ID: 33338475
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a fluorescent, long chain-bridged bispurine that selectively targets the c-MYC G-quadruplex.
Hu MH; Lin JH; Huang Q
Bioorg Chem; 2022 May; 122():105750. PubMed ID: 35325695
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase 1 inhibits MYC promoter activity by inducing G-quadruplex formation.
Keller JG; Hymøller KM; Thorsager ME; Hansen NY; Erlandsen JU; Tesauro C; Simonsen AKW; Andersen AB; Vandsø Petersen K; Holm LL; Stougaard M; Andresen BS; Kristensen P; Frøhlich R; Knudsen BR
Nucleic Acids Res; 2022 Jun; 50(11):6332-6342. PubMed ID: 35687110
[TBL] [Abstract][Full Text] [Related]
16. Identification of G-Quadruplex-Binding Inhibitors of Myc Expression through Affinity Selection-Mass Spectrometry.
Flusberg DA; Rizvi NF; Kutilek V; Andrews C; Saradjian P; Chamberlin C; Curran P; Swalm B; Kattar S; Smith GF; Dandliker P; Nickbarg EB; O'Neil J
SLAS Discov; 2019 Feb; 24(2):142-157. PubMed ID: 30204533
[TBL] [Abstract][Full Text] [Related]
17. Nucleic acid clamp-mediated recognition and stabilization of the physiologically relevant MYC promoter G-quadruplex.
Hao T; Gaerig VC; Brooks TA
Nucleic Acids Res; 2016 Dec; 44(22):11013-11023. PubMed ID: 27789698
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein.
González V; Guo K; Hurley L; Sun D
J Biol Chem; 2009 Aug; 284(35):23622-35. PubMed ID: 19581307
[TBL] [Abstract][Full Text] [Related]
19. Anti-cancer activity of benzoxazinone derivatives via targeting c-Myc G-quadruplex structure.
Jiang S; Awadasseid A; Narva S; Cao S; Tanaka Y; Wu Y; Fu W; Zhao X; Wei C; Zhang W
Life Sci; 2020 Oct; 258():118252. PubMed ID: 32791149
[TBL] [Abstract][Full Text] [Related]
20. New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription.
Hu MH; Wu TY; Huang Q; Jin G
Nucleic Acids Res; 2019 Nov; 47(20):10529-10542. PubMed ID: 31584090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
